{"entity":{"id":"parp-inhibitor-payloads","kind":"term","name":"PARP inhibitor payloads","aka":["PARP1 inhibitor cargo","PARPi antibody-drug conjugates"],"tldr":"A PARP-inhibitor payload attaches a repair-targeting drug to an antibody. A published preclinical abstract describes a TROP2 conjugate carrying a PARP1-selective inhibitor.","summary":"The AACR 2025 abstract describes a TROP2 antibody joined through a cleavable linker to a PARP1-selective inhibitor. Cell comparisons included the conjugate, free payload and antibody alone; a breast-cancer xenograft experiment compared their activity and blood-cell effects. The reported activity varied between tested cell models, illustrating that more delivery antigen is not sufficient to establish payload sensitivity. This is a conference-abstract proof of concept, not clinical evidence that antibody delivery reverses PARP resistance or removes systemic toxicity.","asOf":"2026-11-08","links":[{"label":"Koo et al.: PARP1-selective payload in a TROP2 conjugate, AACR 2025 abstract 5467","url":"https://doi.org/10.1158/1538-7445.am2025-5467"}],"tags":[],"related":["adc","parp","parp-inhibitor","synthetic-lethality","adc-analytes-and-exposure"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["An approved PARP-inhibitor pill, a free PARP drug combined with an ADC and a physically attached PARP payload are different products and evidence questions. Retain the actual conjugated chemical species, linker, release and exposure. A repair-gene variant alone does not prove the tumor’s current functional dependence or establish eligibility for an experimental conjugate."],"category":"ADC chemistry"},"route":"/terms/parp-inhibitor-payloads/","neighbours":{"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"},{"id":"parp-inhibitor","kind":"technology","name":"PARP inhibitors","route":"/technologies/parp-inhibitor/"}],"target":[{"id":"parp","kind":"target","name":"PARP","route":"/targets/parp/"}],"term":[{"id":"adc-analytes-and-exposure","kind":"term","name":"ADC analytes and exposure","route":"/terms/adc-analytes-and-exposure/"},{"id":"synthetic-lethality","kind":"term","name":"Synthetic lethality","route":"/terms/synthetic-lethality/"}]}}